| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/03/2013 | CN103184194A Production of avian reovirus and vaccine by using mammalian cell line |
| 07/03/2013 | CN103184171A Mycoplasma hyopneumoniae DJ-166 strain and application thereof |
| 07/03/2013 | CN103183739A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 07/03/2013 | CN103183738A Compositions and methods of use for antibodies of c-MET |
| 07/03/2013 | CN103183737A Anti-TOM22 protein monoclonal antibody and application thereof |
| 07/03/2013 | CN103183736A Anti-CLCN7 protein monoclonal antibody and application for same |
| 07/03/2013 | CN103183735A Anti-HIV genetic engineering divalent antibody and preparation method thereof, and anti-HIV genetic engineering medicine |
| 07/03/2013 | CN103183734A Mutant protein with unnatural amino acids and application thereof |
| 07/03/2013 | CN103183728A Polypeptide used for preparing O type peptide vaccine of cattle foot-and-mouth disease and preparation methods and applications thereof |
| 07/03/2013 | CN103182090A Dna疫苗 Dna Vaccine |
| 07/03/2013 | CN103182082A Bivalent live vaccine for avian infectious bronchitis and preparation method thereof |
| 07/03/2013 | CN103182081A Preparation of rabies vaccine for human being |
| 07/03/2013 | CN103182080A Avian infectious laryngotracheitis-fowl pox combined active vaccine |
| 07/03/2013 | CN103182079A Respiratory syncytial virus vaccine and preparation method thereof |
| 07/03/2013 | CN103182078A Rotavirus vaccine and preparation method thereof |
| 07/03/2013 | CN103182077A Application of serum 4 type haemophilus parasuis vaccine strain |
| 07/03/2013 | CN103182076A Swine mycoplasma pneumoniae inactivated vaccine and preparation method thereof |
| 07/03/2013 | CN102671208B Heat-resisting freeze-dried protective agent for live vaccine for chicken infectious bursal diseases and preparation method for heat-resisting freeze-dried protective agent |
| 07/03/2013 | CN102626520B Application of heat-resisting cryoprotectant of mink canine distemper live vaccine |
| 07/03/2013 | CN102532271B Brucella B cell epitope and monoclonal antibody and application thereof |
| 07/03/2013 | CN102512674B Fish broad-spectrum vibrio subunit vaccine and preparation method |
| 07/03/2013 | CN102432673B Brucella bp26 protein epitope, monoclonal antibody and application thereof |
| 07/03/2013 | CN102344913B Construction of rabies virus G protein expression recombinant canine distemper virus CDV/R-20/8 vaccine strain |
| 07/03/2013 | CN102302771B Polyvalent inactivity vaccine for preventing and treating atrophic rhinitis of swine |
| 07/03/2013 | CN102281900B Stabilising excipient for inactivated whole-virus vaccines |
| 07/03/2013 | CN102038944B Method for industrially producing swine fever live vaccine by using bioreactor |
| 07/03/2013 | CN101965403B Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 07/03/2013 | CN101948536B Porcine transmissible gastroenteritis virus (PTGEV) and porcine epidemic diarrhea virus (PEDV) dual yolk antibody and preparation method thereof |
| 07/03/2013 | CN101854946B Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 07/03/2013 | CN101712949B gM-negative EHV-mutants without heterologous elements |
| 07/03/2013 | CN101695571B Method for producing swine fever vaccine by using bioreactor and swine fever vaccine product |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/03/2013 | CN101610787B Method for replicating influenza virus in culture |
| 07/03/2013 | CN101502648B Vaccine |
| 07/03/2013 | CN101481406B H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/03/2013 | CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 07/03/2013 | CN101379183B Rescue of influenza virus |
| 07/03/2013 | CN101014625B Novel anti-IGF-IR antibodies and uses thereof |
| 07/02/2013 | US8476416 comprises a dinucleotide analog that includes a non-naturally occurring pyrimidine base; for treating autoimmune disorders, such as autoimmune asthma; allergies |
| 07/02/2013 | US8476409 Bispecific anti-IGF-1R and anti-ErbB3 antibodies |
| 07/02/2013 | US8476237 Compositions and methods for treating cancer by inhibiting the secretion of microparticles |
| 07/02/2013 | US8476230 Insulinotropic complex using an immunoglobulin fragment |
| 07/02/2013 | US8476024 Botulinum neurotoxin a protein receptor and uses thereof |
| 07/02/2013 | US8475810 Attenuated Salmonella enterica serovar paratyphi a and uses thereof |
| 07/02/2013 | US8475809 Composition comprising sortase anchored surface proteins of Streptococcus uberis |
| 07/02/2013 | US8475808 Immunogenic reagents from west nile virus |
| 07/02/2013 | US8475806 High titer recombinant influenza viruses for vaccines and gene therapy |
| 07/02/2013 | US8475805 Methods of reducing concomitant infections in pigs with a PCV2 antigen |
| 07/02/2013 | US8475803 Assays for diagnosis of tuberculosis and uses thereof |
| 07/02/2013 | US8475802 Peptide sequences and compositions |
| 07/02/2013 | US8475801 IgE CH3 peptide vaccine |
| 07/02/2013 | US8475800 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies |
| 07/02/2013 | US8475799 HIV-1 GP41 neutralization domain and use thereof |
| 07/02/2013 | US8475798 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 07/02/2013 | US8475797 Interferon alpha antibodies and their uses |
| 07/02/2013 | US8475796 Method of treating pain using an antagonist of GM-CSF |
| 07/02/2013 | US8475794 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases |
| 07/02/2013 | US8475793 Engineered anti-TSLPR antibodies |
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | US8475791 Anti-IL-TIF antibodies and methods of use |
| 07/02/2013 | US8475790 Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases |
| 07/02/2013 | US8475789 Products and methods to prevent infections |
| 07/02/2013 | US8475787 Beneficial effects of bacteriophage treatments |
| 07/02/2013 | US8475785 Allogeneic cancer cell-based immunotherapy |
| 07/02/2013 | US8475776 Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| 07/02/2013 | US8475767 Anti-trypanosomal peptides and uses thereof |
| 07/02/2013 | US8475766 Dual specificity antibodies and methods of making and using |
| 07/02/2013 | CA2717038C Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 07/02/2013 | CA2601360C Sclerostin and the inhibition of wnt signaling and bone formation |
| 07/02/2013 | CA2585977C Remedy for endometriosis |
| 07/02/2013 | CA2576571C Preparation of antigen-presenting human .gamma..delta. t cells and use in immunotherapy |
| 07/02/2013 | CA2576419C Enzyme inhibitor in leukemia |
| 07/02/2013 | CA2564974C Immune response stimulating composition comprising methyl vinyl ether-maleic anhydride copolymer-based nanoparticles |
| 07/02/2013 | CA2562904C Cancer treatment using viruses and camptothecins |
| 07/02/2013 | CA2542044C Fully human antibodies against human 4-1bb (cd137) |
| 07/02/2013 | CA2533559C Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 07/02/2013 | CA2507915C Recombinant viral-based malaria vaccines |
| 07/02/2013 | CA2455701C The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/02/2013 | CA2446131C Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 07/02/2013 | CA2428270C Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 07/02/2013 | CA2421151C Modified vaccinia ankara virus variant |
| 07/02/2013 | CA2401974C Dna expression vectors and methods of use |
| 07/02/2013 | CA2379012C In vitro reconstitution of segmented negative-strand rna viruses |
| 07/02/2013 | CA2251009C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/27/2013 | WO2013096948A1 Immunoglobulins and variants directed against pathogenic microbes |
| 06/27/2013 | WO2013096847A1 Serum amyloid p-antibody fusion proteins |
| 06/27/2013 | WO2013096828A1 Surrogate binding proteins |
| 06/27/2013 | WO2013096812A1 Articles of manufacture and methods for co-administration of antibodies |
| 06/27/2013 | WO2013096791A1 Process for making high concentration protein formulations |
| 06/27/2013 | WO2013096740A1 Methods and compositions for assigning likelihood of chronic kidney disease progression |
| 06/27/2013 | WO2013096516A1 Methods for treating acne |
| 06/27/2013 | WO2013096430A1 Method of treating cancer with magea3 immunotherapeutic with braf inhibitor and/or mek inhibitor |
| 06/27/2013 | WO2013096346A1 Bispecific t-cell activator antibody |
| 06/27/2013 | WO2013096335A1 Administration of an antagonist of alpha 5 beta 1 for anti-antiogenesis and cancer treatment |
| 06/27/2013 | WO2013096166A1 PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS |
| 06/27/2013 | WO2013095966A1 Non-sialylated anti-inflammatory polypeptides |
| 06/27/2013 | WO2013095965A1 Stable storage of enveloped viruses in histidine aqueous solution |
| 06/27/2013 | WO2013095781A1 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses |
| 06/27/2013 | WO2013095738A2 Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins |
| 06/27/2013 | WO2013095189A1 Symbiotic strain corynebacteriae diphtheriae tox-n108 used for the preparation of an immunomodulator |